Cytogenetics and molecular genetics in multiple myeloma

Hematology/Oncology Clinics of North America

Volumn 11, Issue 1, 1997, Pages 1-25

  Feinman, R ^a   Sawyer, J ^a   Hardin, J ^a   Tricot, G ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER SURVIVAL; CYTOGENETICS; HUMAN; KARYOTYPE; MULTIPLE MYELOMA; PRIORITY JOURNAL; REVIEW;

EID: 0030991361     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70412-3     Document Type: Article

References (108)

1. D. Ayer L. Kretzner R.N. Eisenman Mad: A heterodimeric partner for max that antagonizes myc transcriptional activity Cell 72 1993 211
2. D.E. Ayer A. Lawrence R.N. Eisenman The amino-terminus of mad mediates ternary complex formation with mammalian homologs of yeast repressor Sin3 and is required for Mad:Max transcriptional repression Cell 80 1995 767
3. B. Barlogie J. Epstein P. Selvanayagam Plasma cell myeloma—new biological insights and advances in therapy Blood 73 1989 865
4. R. Bataille M. Boccadoro B. Klein C-reactive protein and β-2 microglobulin produce a simple and powerful myeloma staging system Blood 80 1992 733
5. R.L. Beijersbergen E.M. Hijmans R. Bernards Interaction of c-myc with the pRB related protein p107 results in the inhibition of c-myc-mediated transactivation EMBO J 13 1994 4080
6. D. Billadeau D.F. Jelinek N. Shah Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6 Cancer Res 55 1995 3640
7. E.M. Blackwood R.N. Eisenman Max: A helix-loop-helix-zipper protein that forms a sequence specific DNA binding complex with myc Science 251 1991 1211
8. M.V. Blagosklonny T. Schulte P. Nguyen Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-raf-1 and represents a novel c-raf-1 signal transduction pathway Cancer Res 56 1996 1851
9. R. Bookstein J.Y. Shew P.L. Chen Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene Science 247 1990 712
10. T.G. Boulton N. Stahl G.D. Yancopoulos Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors J Biol Chem 269 1994 11648
11. H.R. Bourne D.A. Sanders F. McCormick The GTPase superfamily: Conserved structure and molecular mechanism Nature 349 1991 117
12. R.D. Brown B. Pope X.F. Luo The oncoprotein phenotype of plasma cells from patients with multiple myeloma Leuk Lymphoma 16 1994 147
13. M. Chesi P. Bergsagel L. Brents Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines Blood 88 1996 674
14. R.E. Clark A.D. Geddes J.A. Whittaker Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma Eur J Cancer Clin Oncol 25 1989 1789
15. C. Cordon-Cardo E. Latres M. Drobnjak Molecular abnormalities of mdm2 and p53 in adult soft tissue sarcomas Cancer Res 54 1994 794
16. P. Corradini G. Inghirami M. Astolli Inactivation of tumor suppressor genes, p53 and RB-1 in plasma cell dyscrasias Leukemia 8 1994 758
17. D. Dao J. Sawyer J. Epstein Deletion of the retinoblastoma gene in multiple myeloma Leukemia 8 1994 1280
18. P.A. Davol F.A. Goulette A.R. Frackelton Modulation of p53 expression by human recombinant interferon-2a correlates with abrogation of cisplatin resistance in a human melanoma cell line Cancer Res 56 1996 2522
19. G. Dewald R. Kyle G. Hicks The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis Blood 66 1985 380
20. L.A. Downhower M. Harvey B.L. Slagle Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors Nature 356 1992 215
21. J. Downward Regulatory mechanisms for ras proteins Bioessays 14 1992 177
22. J. Drach J. Angerler J. Schuster Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cell from patients with monoclonal gammopathy of undetermined significance Blood 86 1995 3915
23. J. Drach J. Schuster H. Nowotny Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization Cancer Res 55 1995 3854
24. B. Drewinko R. Alexanian H. Boyer The growth fraction of human myeloma cells Blood 57 1981 333
25. W.S. El-Deiry T. Tokino Velculesco WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817
26. H.E. Eliot M.M. Borner B.K. Sinha Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: Implications for etoposide resistance Anticancer Res 15 1995 729
27. L.A. Feig The many roads that lead to Ras Science 260 1993 767
28. P. Fenaux C. Preudhomme J.L. Lay Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: A report on 283 cases Br J Haematol 73 1989 61
29. M. Ffrence P. Ffrench F. Remy Plasma cell proliferation in monoclonal gammopathy: Relations with other biologic variables—diagnostic and prognostic significance Am J Med 98 1995 61
30. Field S.J. Tasi F.-Y. F. Kuo E2F1 functions in mice to promote apoptosis and suppress proliferation Cell 85 1996 549
31. J. Garcia-Marco C. Caldas C. Price Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia Blood 88 1996 1568
32. A. Gerone F. Dammacco Molecular alterations of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance Br J Haematol 93 1996 623
33. J. Gould R. Alexanian A. Goodacre Plasma cell karyotype in multiple myeloma Blood 71 1988 453
34. P.R. Greipp J.A. Lust W.M. O'Fallon Plasma cell labeling index and β2-microglobulin predict survival independent of thymidine kinase and c-reactive protein in multiple myeloma Blood 81 1993 3382
35. D.A. Haas-Kogan S.C. Kogan D. Levi Inhibition of apoptosis by the retinoblastoma gene product EMBO J 14 1995 461 472
36. S. Haldar N. Jene C.M. Croce Inactivation of bcl-2 by phosphorylation Proc Natl Acad Sci USA 92 1995 4507
37. A.J. Hale C.A. Smith L.C. Sutherland Apoptosis: Molecular regulation of cell death Eur J Biochem 236 1996 1
38. M. Hanada D. Delia A.S. Aiello Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia Blood 82 1993 1820
39. J. Hardin S. MacLeod I. Grigorieve Interleukin-6 prevents dexamethasone-induced myeloma cell death Blood 84 1994 3063
40. L. Hartwell Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells Cell 71 1993 543
41. G. Hateboer H.T.M. Timmers A.K. Rustgi TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-myc and adenovirus E1A protein Proc Natl Acad Sci USA 90 1993 8489
42. D.S. Hawkins G.W. Demers D.A. Galloway Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents Cancer Res 56 1996 892
43. M. Hollstein D. Sidransky B. Vogelstein p53 mutations in human cancer Science 250 1990 113
44. R.G. Hoover V. Kaushal C. Lary C-myc transcription is initiated from PO in 70% of patients with multiple myeloma Curr Top Microbiol Immunol 194 1995 257
45. T. Jacks A. Fazeli E. Schmitt Effects of an RB mutation in the mouse Nature 359 1992 295
46. Juge-Morineau N. Mellerin M.-P. S. Francois High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells Br J Haematol 91 1995 664
47. T. Juven Y. Barak A. Zauberman Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene Oncogene 8 1993 3411
48. M.B. Kastan Q. Zhan W.S. El-Deiry A mammalian cell cycle checkpoint utilizing p53 and gadd45 is defective in ataxia-telangiectasia Cell 71 1992 587
49. R. Khosravi-Far C.J. Der The ras signal transduction pathway Cancer Metastasis Rev 13 1994 67
50. H. Kiaria D.A. Spandidos Mutations of ras genes in human tumors Int J Oncol 7 1995 413
51. T. Kinoshita T. Yokata K. Arai Regulation of bcl-2 expression by oncogenic ras protein in hematopoietic cells Oncogene 10 1995 2207
52. T. Kinoshita T. Yokata K. Arai Suppression of apoptotic death in hematopoietic cells by signalling through the IL3/GM-CSF receptors EMBO J 14 1995 266
53. T. Kishimoto S. Akira M. Narazaki Interleukin-6 family of cytokines and gp130 Blood 86 1995 1243
54. H. Kobayashi H. Saito K. Kitano Overexpression of the PRAD1 oncogene in a patient with multiple myeloma Acta Haematol 94 1995 199
55. H. Land L.F. Parada R.A. Weinberg Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes Nature 304 1983 596
56. D.P. Lane p53, guardian of the genome Nature 358 1992 15
57. W.Y. Langdon A.W. Harris S. Cory Acceleration of B-lymphoid tumorigenesis in Eμ-myc transgenic mice by v-Ha-ras and v-raf but not v-abl Oncogene Res 4 1989 253
58. J. Latreille B. Barlogie D. Johnson Ploidy and proliferative characteristics in monoclonal gammopathies Blood 59 1982 43
59. Lee E.Y.-H.P. Cheng C.-Y. N. Hu Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation Genes Dev 8 1994 2008
60. Lee E.Y.-H.P. Chang C.-Y. N. Hu Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis Nature 359 1992 288
61. H. Lee M. Arsura M. Wu Role of rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell line WEHI 231 line J Exp Med 181 1995 1169
62. A. Lichtenstein Y. Tu C. Fady Interleukin-6 inhibits apoptosis of malignant plasma cells Cell Immunol 162 1995 248
63. P. Liu T. Leong L. Quam Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: Analysis of the Eastern Cooperative Oncology Group phase III trial Blood 88 1996 2699
64. Y. Liu L. Szekely D. Grander Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: Evidence for a role of an adjacent locus Proc Natl Acad Sci USA 90 1993 8697
65. H. Lovec A. Grzeschiczek Kowalski M.-B. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice EMBO J 13 1994 3487
66. Luc Lai J. M. Zandecki J. Mary Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis Blood 85 1995 2490
67. M.C. Marin B. Hsu L.C. Stephens The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo Exp Cell Res 217 1995 240
68. T.J. McDonnell S.J. Korsmeyer Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18) Nature 349 1991 6306
69. J.F. Miguel M. Garcia-Sanz M.J. Gonzalez A new staging system for multiple myeloma based on the number of S-phase plasma cells Blood 85 1995 448
70. T. Miyashita J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293
71. T. Miyashita S. Krajewski M. Krajewska Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 9 1994 1799
72. S.D. Morganbesser R.A. DePinho Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer Semin Cancer Biol 5 1994 21
73. A. Neri L. Baldini D. Trecca p53 Gene mutations in multiple myeloma are associated with advance of malignancy Blood 81 1993 128
74. A. Neri D.M. Knowles A. Greco Analysis of ras oncogene mutations in human lymphoid malignancies Proc Natl Acad Sci USA 85 1988 9268
75. J.D. Oliner K.W. Kinzler P.S. Meltzer Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 1992 80
76. F. Ong J. Nieuwkoop de Groot-Swings G.M.J.S. Bcl-2 protein expression is not related to short survival in multiple myeloma Leukemia 9 1995 1282
77. F.E.M. Paulin M.J. West N.F. Sullivan Aberrant translational control of c-myc gene in multiple myeloma Oncogene 13 1996 505
78. D.A. Payne S.K. Tyring S. Kumar Human papillomaviruses (HPV) are associated with multiple myeloma Int J Oncol 9 1996 345
79. Pettersson M. Jernberg-Wiklund Larssin L.-G. Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells Blood 79 1992 495
80. Portier M. Moles J.-P. Mazars G.-R. p53 and ras gene mutations in multiple myeloma Oncogene 7 1992 2539
81. K.M. Ryan G.D. Birnie Myc oncogenes: The enigmatic family Biochem J 314 1996 713
82. O. Sangfelt A. Osterborg D. Grander Response to interferon therapy in patients with multiple myeloma correlates with expression of the bcl-2 oncoprotein Int J Cancer 63 1995 190
83. J. Sawyer J. Waldron S. Jagannath Cytogenetic findings in 200 patients with multiple myeloma Cancer Genet Cytogenet 82 1995 41
84. A.F. Schott I.J. Apel G. Nunez Bcl-xL protects cancer cells from p53-mediated apoptosis Oncogene 11 1995 1389
85. N. Schreiber-Agus L. Chin K. Chen An amino-terminal domain of MxiI mediates anti-myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor Sin3 Cell 80 1995 777
86. L.M. Secker-Walker Prognostic and biologic importance of chromosome findings in acute lymphoblastic leukemia Cancer Genet Cytogenet 49 1990 1
87. P. Selvanayagam M. Blick F. Narni Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma Blood 71 1988 30
88. C.J. Sherr J.M. Roberts Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev 9 1995 1149
89. A. Skopelitou M. Hadiyannakis A. Tsenga Expression of c-myc p62 oncoprotein in multiple myeloma: An immunohistochemical study of 180 cases Anticancer Res 13 1993 1091
90. R.S. Slack P.A. Hamel T.S. Bladon Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells Oncogene 8 1993 1585
91. Tabernero D. San Miguel J. R. Garcia-Sanz Incidence of chromosome numerical changes in multiple myeloma: Fluorescence in situ hybridization analysis using 15 chromosome-specific probes Am J Pathol 149 1996 153
92. R. Takahashi T. Hashimoto H.J. Xu The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells Proc Natl Acad Sci USA 88 1991 5257
93. Thulasi R. Harbour D.V. E.B. Thompson Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis J Biol Chem 268 1993 18306
94. E. Tian B. Barlogie S. Jagannath Deletion of the Rb gene in plasma cells from human multiple myeloma patients does not correlate with decreased Rb-1 protein expression nor with upregulation of IL-6 Proc Am Assoc Can Res 36 564(3362a) 1995
95. G. Tricot B. Barlogie S. Jagannath Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities Blood 86 1995 4250
96. Y. Tsujimoto C.M. Croce Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymnphoma Proc Natl Acad Sci USA 83 1986 5214
97. Tu Y. Xu F.-H. J. Liu Upregulated expression of bcl-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide Blood 88 1996 1805
98. E.J. Uhlmann C. D'sa-Eipper T. Subramanian Deletion of a nonconserved region of bcl-2 confers a novel gain of function: Suppression of apoptosis with concomitant cell proliferation Cancer Res 56 1996 2506
99. M. Urashima A. Ogata D. Chauhan Transforming growth factor-beta 1: Differential effects on multiple myeloma versus normal cells Blood 87 1996 1928
100. D.L. Vaux S. Cory J.M. Adams Bcl-2 oncogene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells Nature 335 1988 440
101. H. Weh K. Gutensohn J. Selbach Karyotype in multiple myeloma and plasma cell leukaemia Eur J Cancer 9 1993 1269
102. R. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323
103. L. Yamasaki T. Jacks R. Bronson Tumor induction and tissue atrophy in mice lacking E2F-1 Cell 85 1996 537
104. E. Yang S.J. Korsmeyer Molecular thanatopsis: A discourse on the bcl2 family and cell death Blood 88 1996 386
105. Y. Yasuga S. Hirosawa K. Yamamoto N-ras and p53 gene mutations are very rare events in multiple myeloma Int J Hematol 62 1995 91
106. M. Zandecki Multiple myeloma: Almost all patients are cytogenetically abnormal Br J Haematol 94 1996 217
107. M. Zandecki V. Obein F. Bernardi Monoclonal gammopathy of undetermined significance: Chromosome changes are a common finding within bone marrow plasma cells Br J Haematol 90 1995 693
108. A. Zervos J. Gyuris R. Brent Mxi1, a protein that specifically interacts with max to bind myc-max recognition sites Cell 72 1993 223